临床肺癌 SCISCIE

期刊简介预计审稿时间：较慢,6-12周

Clinical Lung Cancer is a peer-reviewed bimonthly journal that publishes original articles describing various aspects of clinical and translational research of lung cancer. Clinical Lung Cancer is devoted to articles on detection, diagnosis, prevention, and treatment of lung cancer. The main emphasis is on recent scientific developments in all areas related to lung cancer. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.

Clinical Lung Cancer 是一份经过同行评审的双月刊，发表描述肺癌临床和转化研究各个方面的原创文章。临床肺癌致力于肺癌的检测、诊断、预防和治疗方面的文章。主要重点是与肺癌相关的所有领域的最新科学发展。感兴趣的具体领域包括临床研究和机械方法；药物敏感性和耐药性；基因和反义疗法；病理学、标志物和预后指标；化学预防策略；多模式治疗；以及各种方法的整合。

《Clinical Lung Cancer》(临床肺癌)编辑部通讯方式为CIG MEDIA GROUP, LP, 3500 MAPLE AVENUE, STE 750, DALLAS, USA, TX, 75219-3931。如果您需要协助投稿或润稿服务，您可以咨询我们的客服老师。我们专注于期刊投稿服务十年，熟悉发表政策，可为您提供一对一投稿指导，避免您在投稿时频繁碰壁，节省您的宝贵时间，有效提升发表机率，确保SCI检索（检索不了全额退款）。我们视信誉为生命，多方面确保文章安全保密，在任何情况下都不会泄露您的个人信息或稿件内容。